Pfizer Inc. (NYSE:PFE) tshaj tawm hnub no tias lub tuam txhab yuav pib xa khoom ntawm INFLECTRA® (infliximab-dyyb) rau kev txhaj tshuaj, biosimilar ntawm REMICADE®1 (infliximab) rau wholesalers hauv Tebchaws Meskas (Asmeskas) thaum lub Kaum Ib Hlis 2016.
Lub tuam txhab tshuaj dab tsi ua rau INFLECTRA?
Remicade yog kev lag luam los ntawm Janssen Biotech, Inc. (yav dhau los Centocor Biotech, Inc.)
Leej twg yog tus tsim khoom ntawm INFLECTRA?
Inflectra yog tsim los ntawm Celltion, Inc, raws li nyob rau hauv Yeonsu-gu, Incheon, Republic of Kauslim, rau Hospira, ntawm Lake Forest, Illinois. Remicade yog lag luam los ntawm Janssen Biotech, Inc., raws li hauv Horsham, Pennsylvania.
Leej twg ua generic infliximab?
Pfizer tshaj tawm rau 17 Lub Kaum Hli 2016 tias nws yuav pib xa khoom ntawm nws cov monoclonal antibody biosimilar Inflectra (infliximab-dyyb) mus rau Tebchaws Meskas thaum lub Kaum Ib Hlis 2016. Cov xov xwm raws li Asmeskas Food and Drug Administration pom zoo ntawm Inflectra nyob rau lub Plaub Hlis 2016 [1].
Puas yog Remicade thiab INFLECTRA hloov pauv tau?
Nyob rau hauv kev tshawb fawb, INFLECTRA tsis pom muaj qhov sib txawv hauv kev kho mob los ntawm Remicade Qhov no txhais tau tias INFLECTRA yuav tsum ua haujlwm tib yam li Remicade. Koj lossis koj tus kws kho mob yuav xav txog kev kho mob nrog INFLECTRA yog tias koj tshiab rau infliximab kho, lossis yog tias koj tab tom noj Remicade.
